Company intelligence / Profile preview

LAT Research

Ownership: Private
Development stage: Other

Overview

Over 15 years of experience as a full-service CRO in Latin America. Conducted more than 70 clinical studies enrolling over 15,000 patients. Recognized for technical excellence and regulatory reliability. Fast-track regulatory approvals (2–3 months) and country start-up times (~5 months). Strong relationships with top-performing sites and patient organizations for rare diseases. All procedures are audited/certified for GCP compliance.

Therapeutic areas: OtherRare Diseases
Modalities: Small moleculesBiologicsBiomarker-driven studies
Industry: Contract Research Organization

Partnerships

Small/mid-sized biotechsTop pharmaceutical companies (“top 20 pharma”)Academic sponsors worldwide

Beyond the preview

Go deeper on LAT Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LAT Research.

Explore the full profile